The marijuana industry is quite heavily dominated by the largest five growers in the market. These companies have taken over space and seem to get all the focus from investors. Despite this, it appears as though there is a large amount of potential lying in the companies that may not get as much attention as others. These businesses are putting forward a large amount of innovation for the future of the industry that could be potentially met with a high quantity of success in the coming years.
CLS Holdings USA (CLSH) is a company with hands in a large amount of the cannabis industry. The company has been working as an integrated producer of marijuana through their various subsidiaries but most notably, Oasis Cannabis. CLS Holdings, which stands for Cannabis Life Sciences, has been working on a proprietary method of producing cannabis extractions which are of extremely high quality and consistency. With licensing operations, processing, processing facilities, product sales, and brand creation, they look well on their way to becoming one of the more established cannabis companies in the industry.
Recently, the company announced that they are bringing on Gregg Carlson as the Chief Financial Officer. For some background on Mr. Carlson, he previously worked with a private company that owns a large range of Essence Cannabis Dispensaries and Desert Grown Farms, both based out of Las Vegas. The company itself be sold toward the end of the year for around $290 million to the public company, Green Thumb Industries.
Jeff Binder, CEO, and Chairman of CLS Holdings stated that “we conducted an extensive search to fill this position and are thrilled with Gregg agreeing to join CLS. His prior public company experience will be invaluable to us and residing in Las Vegas has made for a smooth transition.”
One of the key factors of success for CLS Holdings has been their location in the Las Vegas, Nevada area. Nevada and specifically Las Vegas has become one of the fastest growing cannabis markets in the whole of the industry. With so much in the works regarding the massive amount of cannabis tourism that they could see, it appears as though Nevada has a large amount of potential for the coming years in the market. Investors should continue to keep a close eye on CLS Holdings.
GW Pharmaceuticals (NASDAQ:GWPH) is not a pure play cannabis stock by any means. The company works primarily in the pharmaceutical business as a producer of various cannabis-derived medicines. Their main claim to fame has been the production of the drugs Epidiolex and Sativex, which are both used to treat rare forms of epilepsy disorders.
Because of their approval from the FDA in the U.S., they have seen a very large amount of growth in recent times. With the introduction of legal hemp production as well, they look as though their future could have even more potential as they continue to make big waves in the marijuana industry.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and CLS Holdings USA Inc. (CLSH), Midam has been paid $200,000 from CLS Holdings USA Inc. (CLSH) for a period from April 26, 2019 to May 26, 2019. We may buy or sell additional shares of (CLSH) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about CLS Holdings USA Inc. (CLSH).
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers